Airbus and the Toulouse IUCT Oncopole signed a two-year partnership on March 3, 2022 to develop projects in the field of artificial intelligence and data analysis. The agreement aims to accelerate cancer research.
With this partnership, the aeronautics giant is taking on a new challenge. Airbus has just put itself at the service of health by signing, this Thursday, March 3, 2022, a partnership with the Oncopole of Toulouse. Two references in their field who will work hand in hand for a single goal: accelerate cancer research.
This unprecedented collaboration will focus on the use of artificial intelligence. Clearly, Airbus engineers will bring all their expertise to doctors to optimize the diagnosis and monitoring of the state of health of patients.
Airbus has developed capabilities to monitor the state of aircraft fleets, but also to extract information from images that could potentially be of interest to the IUCT-Oncopole.
This cooperation around digital platforms for data processing, the latest technologies in terms of big data, cloud and artificial intelligence, should therefore allow the two parties to mutually enrich their know-how and advance the innovation in each sector.
Marc Hamy, General Affairs Director of Airbus
–
The European aircraft manufacturer and the IUCT Oncopole are confronted every day with the management of thousands of data, aircraft for one, patients for the other. To strengthen their security and their expertise, the two players intend to pool their know-how in the field of artificial intelligence (AI).
We hope to accelerate the development of increasingly personalized medical innovations. Health is also an area where AI has been used for many years and certain technologies developed for medical applications could enrich the capabilities currently used for aerospace.
Pr Jean-Pierre Delord, administrator of the IUCT-Oncopole
–
Other projects with AI are in development at the Oncopole to model the monitoring of patients at home, to gain precision in radiotherapy but also to improve diagnosis by medical imaging or the characterization of tumors on slides.
“All these advances are possible thanks to the public/private collaborations that we have been able to develop for several years, and we are delighted to continue this shift in artificial intelligence with the world leader in aeronautics” concludes Professor Delord.
–
